# Paul Peter Tak
Episod podcast teratas
Dikemas kini:
Top podcast episodes featuring paul peter tak.
A Single Injection set to Eliminate Cancer? CEO of Candel Therapeutics - Paul Peter Tak
What if a single injection could teach the immune system to eliminate cancer, and keep it away?
This week, in another episode of Leading Beyond the Lab, Lawrence Rose sits down with Paul Peter Tak, MD, PhD, FMedSci, President & CEO of Candel Therapeutics, one of the most quietly compelling stori ...
BSR and BHPR guidelines on the use of rituximab – (Feb 2012)
How do you manage refractory rheumatoid arthritis? Listen to Professor Robert Moots, Editor, and Professor Paul Peter Tak from the University of Amsterdam, discuss advances in the treatment of RA and consider differences between clinical trials and r
BSR and BHPR guidelines on the use of rituximab – (Feb 2012)
How do you manage refractory rheumatoid arthritis? Listen to Professor Robert Moots, Editor, and Professor Paul Peter Tak from the University of Amsterdam, discuss advances in the treatment of RA and consider differences between clinical trials and r
BSR and BHPR guidelines on the use of rituximab – (Feb 2012)
How do you manage refractory rheumatoid arthritis? Listen to Professor Robert Moots, Editor, and Professor Paul Peter Tak from the University of Amsterdam, discuss advances in the treatment of RA and consider differences between clinical trials and r
BSR and BHPR guidelines on the use of rituximab – (Feb 2012)
How do you manage refractory rheumatoid arthritis? Listen to Professor Robert Moots, Editor, and Professor Paul Peter Tak from the University of Amsterdam, discuss advances in the treatment of RA and consider differences between clinical trials and r
BSR and BHPR guidelines on the use of rituximab – (Feb 2012)
How do you manage refractory rheumatoid arthritis? Listen to Professor Robert Moots, Editor, and Professor Paul Peter Tak from the University of Amsterdam, discuss advances in the treatment of RA and consider differences between clinical trials and r
Francesca Barone - Chief Scientific Officer, Candel Therapeutics
How far can curiosity take you when you’re not afraid of the unknown? For today’s guest, Francesca Barone, it led her across continents and disciplines as she navigated her way to the forefront of cancer immunotherapy. Francesca is the Chief Scientific Officer at Candel Therapeutics, and on this ...
HCW 2026: As it approaches a BLA filing for its viral immunotherapy in prostate cancer, Candel has published its pivotal phase 3 data in Lancet Oncology and presented extended data at AUA
CEO Paul Peter Tak walks us through how the data has settled, and the steps the company needs to take before officially filing the BLA in Q4. Plus, an update on lung cancer.
Engineered Viral Immunotherapy Shows Promise Across Multiple Solid Tumors with Dr. Paul Peter Tak Candel Therapeutics TRANSCRIPT
Dr. Paul Peter Tak, President and CEO of Candel Therapeutics, discusses the company's virus-based approach for treating multiple tumor types. Their lead therapy is an oral drug and an engineered adenovirus injected into tumors to deliver a gene that educates the patient's immune cells to recogn ...
Engineered Viral Immunotherapy Shows Promise Across Multiple Solid Tumors with Dr. Paul Peter Tak Candel Therapeutics
Dr. Paul Peter Tak, President and CEO of Candel Therapeutics, discusses the company's virus-based approach for treating multiple tumor types. Their lead therapy is an oral drug and an engineered adenovirus injected into tumors to deliver a gene that educates the patient's immune cells to recogn ...
ENJIN PENCARIAN PODCAST
Anda boleh menggunakan tapak web kami untuk mencari podcast3,826,089dan episod195,993,594mengikut orang, tempat atau topik.
Pelaburan dalam ilmu memberikan pulangan terbaik, jadi saya mendengar podcast.
‐ Benjamin "Llamacorn" Franklin
SUNTING
Terima kasih kerana membantu memastikan pangkalan data podcast dalam keadaan terkini.
